The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
24 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $997,934 in first-year total cost, median $41,229.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-H (M1)]24
Most frequent institutions
- DARTMOUTH COLLEGE1
- DUKE UNIVERSITY1
- EMORY UNIVERSITY1
- HARVARD MEDICAL SCHOOL1
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Epigenetic mechanisms regulate cancer development and tumor immune responses1F99CA264315-01 | EGOLF, SHAUN ALAN | UNIVERSITY OF PENNSYLVANIA, PA | $47,536 | ZCA1 |
| 2021 | Dissecting mechanisms of inflammation driven cancer susceptibility in epithelial barrier tissues1F99CA264439-01 | COWLEY, CHRISTOPHER | ROCKEFELLER UNIVERSITY, NY | $47,536 | ZCA1 |
| 2021 | Understanding Memory T-Cell responses to cancer and the role of microbiome.1F99CA264434-01 | HAN, JICHANG | DARTMOUTH COLLEGE, NH | $47,536 | ZCA1 |
| 2021 | Investigating the tumor-immune interactome in metastases1F99CA264425-01 | WEIZMAN, ORR-EL | YALE UNIVERSITY, CT | $47,536 | ZCA1 |
| 2021 | Matrix Accumulation in the Metastatic Niche1F99CA264734-01 | LIBRING, SARAH | PURDUE UNIVERSITY, IN | $47,536 | ZCA1 |
| 2021 | Biochemical studies of aberrant chromatin regulation in cancer1F99CA264420-01 | PRESCOTT, NICHOLAS | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $47,536 | ZCA1 |
| 2021 | Metabolic reprogramming and tumor progression in LKB1 deficient NSCLC1F99CA264407-01 | BOESE, AUSTIN C | EMORY UNIVERSITY, GA | $47,536 | ZCA1 |
| 2021 | Toward safe, systemic immunotherapies for treatment of metastatic disease: Developing dendritic cell-biased immunomodulators with precise control over magnitude and timing of immune stimulation1F99CA264404-01 | BHAGCHANDANI, SACHIN | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $46,036 | ZCA1 |
| 2021 | Reprogramming Metabolic Networks in the Tumor Microenvironment1F99CA264414-01 | KERK, SAMUEL ANDREW | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $45,470 | ZCA1 |
| 2021 | Translational use of focused ultrasound to increase blood-tumor barrier permeability as a mechanism to increase drug accumulation into brain metastases of breast cancer1F99CA264445-01 | ARSIWALA, TASNEEM | WEST VIRGINIA UNIVERSITY, WV | $43,027 | ZCA1 |
| 2021 | Targeting intracellular trafficking for cancer therapy1F99CA264430-01 | FINICLE, BRENDAN TYLER | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $42,358 | ZCA1 |
| 2021 | Predoctoral to Postdoctoral Research Training in ctDNA Biology for Liquid Biopsy of Cancer1F99CA264398-01 | CHENG, JORDAN C | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $42,028 | ZCA1 |
| 2021 | A visible machine learning system to discover targeted treatment solutions in cancer1F99CA264422-01 | QIN, YUE | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $40,429 | ZCA1 |
| 2021 | Comprehensive profiling of the tumor microenvironment to predict patient response to immunotherapy1F99CA264307-01 | GREENWALD, NOAH | STANFORD UNIVERSITY, CA | $40,010 | ZCA1 |
| 2021 | Aberrant Glycogen Modulates Metabolism in Ewing’s Sarcoma1F99CA264165-01 | YOUNG, LYNDSAY E A | UNIVERSITY OF KENTUCKY, KY | $39,659 | ZCA1 |
| 2021 | Understanding the impact that tumor representative oxygen tension has on phosphotyrosine-dependent signaling networks in solid tumors1F99CA264162-01 | MAYRO, BENJAMIN JACOB | DUKE UNIVERSITY, NC | $39,466 | ZCA1 |
| 2021 | The Role of dyadic factors on psychosocial wellbeing and healthcare interactions among childhood cancer survivors, parents, and medical providers: A mixed method approach1F99CA264294-01 | OCHOA-DOMINGUEZ, CAROL | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $38,862 | ZCA1 |
| 2021 | Fibrotic remodeling of lymph nodes disrupts T cell function in fibrosis and cancer1F99CA264411-01 | BINGHAM, GRACE C | UNIVERSITY OF VIRGINIA, VA | $37,208 | ZCA1 |
| 2021 | Improving targeted therapy for women's cancers1F99CA264437-01 | YEE, SAMANTHA | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $36,776 | ZCA1 |
| 2021 | Optimizing adherence to lung cancer screening: Applying theory and implementation science to participant engagement1F99CA264409-01 | HIRSCH, ERIN | UNIVERSITY OF COLORADO DENVER, CO | $36,391 | ZCA1 |
| 2021 | Exploiting Oncogenic Chromatin Regulators in Cancer Initiation and Progression1F99CA264296-01 | HYDER, USMAN | UT SOUTHWESTERN MEDICAL CENTER, TX | $36,211 | ZCA1 |
| 2021 | Cellular engineering to improve the efficacy and specificity of targeted immunotherapy1F99CA264312-01 | ABDELFATTAH, NOURAN SAIED | HARVARD MEDICAL SCHOOL, MA | $35,358 | ZCA1 |
| 2021 | Metabolic health phenotype, accelerated aging and obesity-related cancer risk and mortality1F99CA264400-01 | KARRA, PRASOONA | UNIVERSITY OF UTAH, UT | $34,357 | ZCA1 |
| 2021 | Single Molecule Biophysics of Intrinsically Disordered Proteins in Disease1F99CA264413-01 | ALSTON, JHULLIAN JAMILLE | WASHINGTON UNIVERSITY, MO | $31,536 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.